Zoetis (ZTS) Hits New 52-Week Low on Dismal Outlook

Core Viewpoint - Zoetis Inc. (NYSE: ZTS) has experienced a significant decline in stock performance, hitting a new 52-week low due to a lowered revenue growth outlook for the full year 2025 [1][3]. Financial Performance - In intra-day trading, Zoetis dropped to a low of $122.03, ultimately closing down 13.78% at $124.46 after reducing its revenue guidance for 2025 to a range of $9.4 billion to $9.475 billion, down from a previous estimate of $9.45 billion to $9.6 billion [2]. - The net income outlook was also revised down to a range of $2.625 billion to $2.665 billion, compared to the earlier forecast of $2.65 billion to $2.7 billion [3]. - For the third quarter, Zoetis reported a 5.7% increase in attributable net income to $721 million, up from $682 million, while revenues remained flat at $2.4 billion [3]. Strategic Positioning - The CEO of Zoetis, Kristin Peck, highlighted that despite moderated growth in the third quarter, the company achieved significant regulatory milestones, including new product approvals and geographic expansions, positioning itself well for future growth [4].